Literature DB >> 16679526

Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia.

Paulo R Batista1, Alan Wilter, Elza H A B Durham, Pedro G Pascutti.   

Abstract

Africa accounts for the majority of HIV-1 infections worldwide caused mainly by the A and C viral subtypes rather than B subtype, which prevails in the United States and Western Europe. In Brazil, B subtype is the major subtype, but F, C, and A also circulate. These non-B subtypes present polymorphisms, and some of them occur at sites that have been associated with drug resistance, including the HIV-1 protease (PR), one important drug target. Here, we report a Molecular Dynamics study of the B and non-B PR complexed with the inhibitor ritonavir to delineate the behavior of each subtype. We compare root mean squared deviation, binding free energy by linear interaction energy approach, hydrogen bonds, and intermolecular contact surface area between inhibitor and PR. From our results, we can provide a basis to understand the molecular mechanism of drug resistance in non-B subtypes. In this sense, we found a decrease of approx 4 kcal/mol in deltaG of binding between B and non-B subtypes. This corresponds to the loss of one hydrogen bond, which is in agreement with our H-bond analysis. Previous experimental affinity studies reported analogous results with inhibition constant values for non-B PR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679526     DOI: 10.1385/CBB:44:3:395

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  8 in total

1.  Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease.

Authors:  Roxana M Coman; Arthur Robbins; Maureen M Goodenow; Robert McKenna; Ben M Dunn
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-30

2.  Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.

Authors:  Konda Reddy Karnati; Yixuan Wang
Journal:  J Mol Graph Model       Date:  2019-07-18       Impact factor: 2.518

3.  The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics.

Authors:  Xi Huang; Manuel D Britto; Jamie L Kear-Scott; Christopher D Boone; James R Rocca; Carlos Simmerling; Robert Mckenna; Michael Bieri; Paul R Gooley; Ben M Dunn; Gail E Fanucci
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

4.  Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution.

Authors:  Zhanglong Liu; Xi Huang; Lingna Hu; Linh Pham; Katye M Poole; Yan Tang; Brian P Mahon; Wenxing Tang; Kunhua Li; Nathan E Goldfarb; Ben M Dunn; Robert McKenna; Gail E Fanucci
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

5.  Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.

Authors:  Ankita Gupta; Salma Jamal; Sukriti Goyal; Ritu Jain; Divya Wahi; Abhinav Grover
Journal:  BMC Bioinformatics       Date:  2015-12-16       Impact factor: 3.169

6.  Impact of M36I polymorphism on the interaction of HIV-1 protease with its substrates: insights from molecular dynamics.

Authors:  Mauricio G S Costa; Técio G Benetti-Barbosa; Nathan Desdouits; Arnaud Blondel; Paulo M Bisch; Pedro G Pascutti; Paulo R Batista
Journal:  BMC Genomics       Date:  2014-10-27       Impact factor: 3.969

7.  Molecular dynamics simulation in virus research.

Authors:  Hirotaka Ode; Masaaki Nakashima; Shingo Kitamura; Wataru Sugiura; Hironori Sato
Journal:  Front Microbiol       Date:  2012-07-19       Impact factor: 5.640

8.  New insights into the in silico prediction of HIV protease resistance to nelfinavir.

Authors:  Dinler A Antunes; Maurício M Rigo; Marialva Sinigaglia; Rúbia M de Medeiros; Dennis M Junqueira; Sabrina E M Almeida; Gustavo F Vieira
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.